PATENT CLAIM ANALYSIS

Application Number: 15755951
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "001100"]

Abstract:
Provided herein are compounds of Formula (I) and pharmaceutical compositions thereof, which may be useful as MALT1 inhibitors. Also provided are for the treatment of proliferative disorders (e.g., cancer (e.g., non-Hodgkin's lymphoma, diffuse large B-cell lymphoma, MALT, lymphoma), benign neoplasm, a disease associated with angiogenesis, an autoimmune disease, an inflammatory disease, an autoinflammatory disease) by administering a compound of Formula (I).

Claim (Index 23):
The compound of  claim 1 , wherein R 6  is of formula:

Metadata:
- Claim Count in Document: 23.0
- Percentile: 88.0
- Lexical Diversity: 1.59615
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15104132', '15847430', '15847856', '15904143', '14358606']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7974437304248665
- 35 USC 102 Novelty (BERT): 0.5610585713772274
- Combined Prediction Score: 0.7738052145201026
- Mean Citation Score: 416.207098
- Max Citation Score: 435.94302000000016
- Similarity Product: 324.0779006327392

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test